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Introduction
There is increasing interest in the possibility that a high 
intake of refined sugars is associated with detrimental 
effects on metabolism that increase the risk of cardiovas-
cular disease, obesity, insulin resistance and diabetes. Some 
of the evidence underpinning these concerns is derived 
from cross-sectional surveys or ecological observations, 
but there are also prospective cohort studies and controlled 
intervention trials which have addressed this issue. This 
brief narrative review arises from a Symposium on Sugars 
and Health held at the European Nutrition Conference in 
October 2015. It will consider the recent work, published in 
the past 5 years, which has focussed on the potential impact 
of dietary sugars on health, in particular insulin resistance 
and diabetes risk, and seeks to identify the intakes which 
might be associated with health-related problems. The 
terminology employed in these discussions is often used 
rather loosely, with the term ‘sugar’ often being used to 
represent a range of different molecules. For the purposes 
of this article, ‘sugar’ is taken to be the common term for 
sucrose, and the collective term ‘sugars’ will be used to 
include sucrose, glucose and fructose together with the 
high fructose corn syrups which are replacing sucrose in 
sweetened beverages and foods in many countries.
Basic aspects of dietary carbohydrates, insulin 
action and insulin resistance
Dietary carbohydrates include the monosaccharides, disac-
charides, oligosaccharides (chain length 3–9 molecules), 
polysaccharides and fibre. The monosaccharides are glu-
cose, fructose and galactose, and the major disaccharides 
are sucrose (glucose plus fructose), lactose (glucose and 
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galactose) and maltose (2 glucose molecules). The polysac-
charide category represents the starches, which are made 
up of glucose polymers with variation in the location and 
number of cross-linkages between the molecules producing 
different sub-categories of starches. The mono- and disac-
charides are normally combined into the collective category 
of sugars. The main carbohydrate contributors to dietary 
energy intake are the sugars and starches. The control of 
carbohydrate metabolism is dependent on appropriate lev-
els of insulin secretion and insulin action. For the purposes 
of the present overview, the issues around insulin secretion 
(particularly as it relates to type 2 DM) will not be consid-
ered. However, the impact of dietary carbohydrates or total 
energy intake on insulin action is worthy of consideration.
Whilst there is currently some controversy over the role 
of carbohydrates in a healthy diet, most if not all national 
guidelines recommend that the proportion of energy con-
tributed by carbohydrate should be approximately 50% 
(e.g. [1]). It has been known for at least 80 years that a low 
carbohydrate/high fat intake is associated with poorer glu-
cose tolerance and insulin resistance [2]. The major con-
cern at present is focussed on dietary sugars, and whether 
an excessive intake of them as a proportion of total car-
bohydrate can lead to insulin resistance and impaired glu-
cose tolerance and lead to an increased risk of developing 
type 2 diabetes mellitus (DM). There is increasing concern 
about the potential threat to health represented by a high 
intake of sugars, as evidenced by the recent Dietary Guide-
lines for Americans [3], UK Scientific Advisory Commit-
tee for Nutrition’s Carbohydrate report [1] and the WHO 
Sugars Report [4]. Although most of the attention has been 
focussed on sucrose and fructose, many studies have failed 
to directly compare fructose and glucose in randomised 
trials, and when direct comparisons have been made, it is 
clear that any impact on health is more likely to be a sugars-
related effect than specifically due to fructose (see later).
This short review will consider this issue in greater detail 
and assess the potential problems of sugars in relation to 
insulin resistance and risk of type 2 DM. The present arti-
cle is a narrative review based on the systematic reviews 
undertaken to inform the SACN Review of Carbohydrates 
and Health. The details of these 3 systematic reviews are 
provided in the SACN report, including the search strate-
gies and the inclusion/exclusion criteria. The additional lit-
erature included in the present review was identified sepa-
rately from this systematic review process, and this was not 
performed using systematic review criteria but was simply 
designed to illustrate some of the additional aspects of this 
field and the more recent observations reported in the past 
5 years. One of the major issues in this area of research is 
the short-term nature of many of the investigations, espe-
cially studies involving alteration of the carbohydrate com-
position of the diet or the types of sugars being consumed. 
Clearly the long-term health effects of such interventions 
can only be speculated about, but such studies do provide 
useful information on potential mechanisms of effects of 
carbohydrates on health.
What are the major issues relating to dietary 
fructose? Contrast between research evidence 
and speculation/opinion
There has been concern expressed for many years that 
sucrose, and particularly fructose, represent potential prob-
lems as far as risks to health are concerned. One of the 
first major critics of sucrose in the diet was John Yudkin 
[5], whose book ‘Pure, white and deadly’ summarised the 
scientific information available in the 1960s/early 1970s 
and promoted his opinion conveyed in the book’s title 
that diabetes, cardiovascular disease and other chronic ill-
nesses were contributed to by a high sucrose intake. In 
more recent times, these views have resurfaced and been 
extended to include the high fructose corn syrup (HFCS) 
content of foods and drinks. These opinions relating to the 
threat to health from fructose alone and as a component of 
sucrose and HFCS, are sustained despite reports such as 
that from the German Nutrition Society, which concluded 
that intakes of up to 100 g fructose per day are not asso-
ciated with increased serum triglycerides and that fructose 
and sucrose are not associated with increased risk of hyper-
tension or CHD [6].
The principal concern raised in relation to fructose is 
that its metabolism promotes lipid synthesis in the liver and 
because it is metabolised independently of insulin action in 
the liver and elsewhere, it can lead to excessive lipid forma-
tion and deposition, insulin resistance and other features of 
the metabolic syndrome. However, the studies which have 
investigated potential effects of fructose on liver fat con-
tent, plasma lipids or insulin sensitivity have often failed 
to include a glucose control treatment, and thus any effect 
ascribed to fructose may simply be an effect of monosac-
charides (see below). Longitudinal cohort studies and eco-
logical observations have been used to associate increased 
obesity with high levels of sucrose, fructose or HFCS 
consumption. For example, Fiorito et al. [7] reported that 
higher sweetened beverage intake in 5-year-old girls was 
associated with increased BMI and adiposity 10 years later, 
whilst Nissinen et al. [8] in the young Finns study reported 
an association between increasing sugar-sweetened bever-
age intake from childhood to adulthood was associated 
with increased adult BMI in women. However, such obser-
vations can at best signal a concern that then needs investi-
gating in controlled trials.
In some cases, the arguments for an increased risk to 
health associated with high intake of fructose arise from 
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reviews of experimental animal studies combined with 
human ecological observations. An example of this is pro-
vided by Johnson et al. [9] who reviewed studies in meta-
bolic syndrome prone rats that developed fatty livers whilst 
receiving 40% of their dietary energy from sucrose. This 
review also attributed to Lustig and colleagues [10], show-
ing an epidemiological association of increased diabetes 
prevalence with increased sugar availability. However, this 
was a population level econometric analysis based on mul-
tiple cross-sectional observations. It is rather speculative 
and undesirable to draw major conclusions of causation or 
association from such a combination of econometric and 
animal data.
There is evidence from other animal experiments of 
effects of sucrose or fructose plus glucose on insulin 
resistance, liver fat content and liver levels of inflamma-
tory markers [11]. However, these rats received 60% of 
their total energy intake as sucrose, or 30% as fructose 
and 30% as glucose. Both of these dietary treatments are 
so extreme; it is not surprising that metabolic abnormali-
ties were observed. Another study fed mice with a diet pro-
viding 38.5% of energy as sucrose and observed elevated 
plasma glucose levels in the early phase of an oral glucose 
tolerance test (OGTT) indicative of insulin resistance or 
impaired insulin release [12]. However, the same study 
showed that sucrose feeding improved insulin sensitivity 
as assessed during an insulin tolerance test. One possible 
explanation of these apparently opposing observations is 
that high levels of sucrose feeding to these mice may have 
led to a reduction in the release of one or more of the incre-
tin hormones from the GI tract during food/glucose inges-
tion, reducing the insulin response to the OGTT and thus 
leading to higher plasma glucose levels.
What is the evidence from randomised controlled 
trials (RCT) of the metabolic effects of fructose or 
sucrose?
Some reviews and commentaries have urged caution in 
attributing major health risks associated with fructose/
sucrose in people. Klurfeld et al. [13] assessed the potential 
link between HFCS and obesity and concluded that the evi-
dence was not supportive of such a claim and commented 
that RCT at levels even exceeding normal human consump-
tion have also been inconclusive related to fructose, sucrose 
and obesity. A subsequent review by Tappy and Mitten-
dorfer [14] commented that whilst some studies describe 
potential adverse effects of high fructose intakes, particu-
larly as part of an excessive energy intake, there does not 
appear to be a significant detrimental effect of fructose 
when part of a weight-maintaining diet. They concluded 
by commenting that definitive studies were missing. Since 
then, a number of RCT have been published which shed 
further light on this issue.
Bravo et al. [15] performed a study in healthy, over-
weight adults which involved providing sweetened low-
fat milk which contained 8, 18 or 30% of estimated daily 
energy requirements in the form of sucrose or HFCS, for 
a period of 10 weeks. There was an increase in reported 
energy intake over the course of the study when all groups 
were combined, and whilst the groups receiving 18 and 
30% of energy from the sugars appeared to have the most 
marked increases, there were no significant increases in any 
group. There was an increase in body weight across the 
study, although this was only significant in the 30% sugars 
groups with mean increases of 1 and 2.3 kg over 10 weeks 
in the 30% sucrose and the 30% HFCS groups. Despite the 
increase in body weight, there were no significant changes 
in the fat content of the liver or skeletal muscles in any 
group. When data for all groups were combined, there was 
a significant increase in plasma triglycerides (from 1.11 to 
1.27 mmol/l), but there were no differences between the 
groups and no significant change within any individual 
group (presumably due to a lack of statistical power). There 
were no changes in plasma cholesterol during the study.
Heden et al. [16] also found no effect of moderate daily 
intakes of mixtures of fructose and glucose for a period of 
2 weeks in physically active adolescents. They consumed 
mixtures containing 50 g fructose and 15 g glucose, or 15 g 
fructose and 50 g glucose, daily for 2 separate 2-week peri-
ods. When these supplements were considered together 
with the dietary fructose and glucose, the total intakes were 
around 70 g fructose and 40 g glucose, compared to 40 g 
fructose and 70 g glucose. The combined sugars intakes 
equated to approximately 25% of total energy intake. There 
were no significant changes in fasting and postprandial 
indices of insulin resistance, or fasting blood lipids with 
either treatment, or any difference in response between 
subjects who were overweight compared to the healthy 
weight subjects.
An interesting study by Aeberli et al. [17] assessed the 
effect of different amounts of fructose or glucose supple-
mentation in a beverage, on insulin sensitivity using the 
glucose clamp technique. Intriguingly, the title of the paper 
is ‘Moderate Amounts of Fructose Consumption Impair 
Insulin Sensitivity in Healthy Young Men’, but the results 
obtained show that the only change in insulin sensitivity 
was a reduction in the degree of insulin-induced suppres-
sion of hepatic glucose production after the high fructose 
drink (80 g/day for 3 weeks) intake compared with the 80 g 
glucose drink. There were no differences in whole body, 
systemic insulin sensitivity and no differences between 
the groups in fasting insulin and glucose concentrations. 
Furthermore, there was no difference in any component of 
insulin sensitivity between the moderate fructose (40 g/day) 
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drink or 80 g sucrose drink and the 80 g glucose control 
drink. This suggests a threshold intake of fructose is needed 
for an effect on hepatic insulin resistance. The total fructose 
intake after the 40 g drink was 77 g/day, whilst the total 
fructose intake after the 80 g drink was 115 g/day. Thus, 
from this study the threshold appears to be somewhere 
between fructose intakes equivalent to 15 and 23% of total 
energy intake. It is interesting to note that there did not 
appear to be any impact of these sugars containing drinks 
on total energy intake compared to the baseline condi-
tion, with some compensatory reductions in protein and fat 
intake balancing the additional energy from sugars. Such 
compensation has not been reported in other studies involv-
ing increased intake of sugars containing drinks. There was 
also no effect on fasting serum triglycerides which is sur-
prising as other studies have shown an increased monosac-
charide intake leads to a rise in triglycerides.
An interesting contrast to the Aeberli study is found in the 
work of Hokayem et al. [18] who studied insulin resistance 
in relatives of people with type 2 DM. Because of their fam-
ily history, such people have an increased risk of developing 
diabetes and are likely to be insulin resistant. The purpose of 
this study was to examine the effects of grape polyphenols 
on the metabolic consequences of short-term consumption 
of a high fructose intake (3 g fructose/kg fat free mass per 
day for 6 days). The fructose intake was designed to induce 
insulin resistance and oxidative stress. The group consuming 
the grape polyphenols did not show any reduction in glucose 
infusion rate during the glucose clamp or any change in the 
fasting insulin sensitivity index after 6 days of fructose con-
sumption. By comparison, the placebo control group had an 
11% reduction in glucose infusion rate and a 19% reduction 
in the fasting insulin sensitivity index.
Stanhope et al. [19] provided obese subjects with 
25% of their energy requirements as glucose or fructose 
for 10 weeks. Both groups had similar increases in body 
weight (+1.8% in the glucose and +1.4% in the fructose 
groups) and body fat content (+3.2 and +2.8%), indicating 
that this was essentially an overfed state. Only the fructose 
group showed an increase in postprandial serum triglyc-
erides (TG) from late afternoon onwards, with no change 
in fasting TG in either group. There was also evidence of 
impaired glucose tolerance with increased insulin responses 
in the fructose group, with no change in the glucose group. 
However, the oral glucose load in the glucose tolerance 
test is not something that the fructose group would have 
been used over the previous weeks, and so without glucose 
clamp-based assessments of insulin resistance, it is difficult 
to interpret the glucose tolerance data.
Lecoultre et al. [20] reported a study of the effects of fruc-
tose, glucose or fat overfeeding for 6 days on hepatic insulin 
sensitivity and intrahepatic lipids in healthy people. Three 
different doses of fructose were investigated, 1.5, 3 and 4 g 
per kg body weight per day, which were additional to the 
diet required to maintain weight. This equated to an excess 
energy intake of 17, 32 and 43% of energy requirements. The 
glucose dose used was 3 g/kg/day (37% overfeeding), and 
the fat overfeeding was at a level of 30% of energy require-
ments. The 3 and 4 g doses of fructose, the glucose and the 
fat overfeeding all increased liver fat content by 50 to 110%, 
with the 3 g fructose dose having a significantly larger effect 
that the 3 g glucose. Interestingly, the smaller degree of over-
feeding with 1.5 g fructose did not increase liver fat content. 
The two higher doses of fructose (but not 1.5 g fructose or 
the glucose or fat overfeeding) also reduced the hepatic insu-
lin sensitivity by about 20%. Thus, high fructose intakes dur-
ing overfeeding did increase liver fat and produce liver insu-
lin resistance, but 100 g of fructose per day (the lowest dose) 
with modest overfeeding did not have such effects.
Stanhope et al. [21] recently reported a study of the 
effects of varying amounts of high fructose corn syrup 
(HFCS) consumed for 2 weeks, with the lowest amount 
being equivalent to 10% of energy requirements. This low-
est quantity represents approximately 5% of total energy 
from fructose and was not associated with any change in 
body weight over the 2 weeks, whilst the 17.5 and 25% 
HFCS groups did have an increase in weight. The 17.5 and 
25% doses of HFCS were accompanied by increases in 
postprandial TG, and the 25% dose also tended to increase 
fasting TG. Interestingly, the 10% HFCS treatment also 
increased postprandial TG in the late evening, indicat-
ing that this effect is not dependent on an increase in body 
weight. No data were presented on glucose and insulin, 
so it is not possible to comment on any effects on insulin 
resistance of this low dose of HFCS.
The overall conclusion from these studies is that a fructose 
intake exceeding 150 g/day in adults reduces fasting insulin 
sensitivity but intakes appear to need to exceed 250 g/day 
before affecting insulin-induced suppression of liver glucose 
output. There is less clarity of potential effects on peripheral 
insulin sensitivity, even at high fructose intakes. The higher 
doses of fructose also appear to increase serum TG, in at least 
some studies, and it is possible that this can occur with low 
doses of fructose in so far as late evening postprandial TG 
are concerned and without an increase in body weight (i.e. 
without overfeeding). It is striking that the majority of these 
observations are linked to situations where high fructose 
intakes are accompanied by excessive energy intakes, and the 
following section considers this in more detail.
Is the effect of fructose or sucrose affected by the 
amount consumed or the total energy intake?
A study of ours directly compared high levels of glucose 
or fructose intake in overweight, large-waisted men who 
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were otherwise healthy [22]. The participants were stud-
ied in two separate 2-week periods, the first when fed at 
energy balance (isoenergetic), with glucose or fructose pro-
viding 25% of total energy intake, and the second, at least 
6 weeks later, when the sugars were added to their ad libi-
tum diet (with a target of 25% overfeeding). The men had 
high initial levels of liver (8%) fat and intramuscular (8%) 
fat at baseline, but there were no significant changes in 
either the fructose or glucose groups when an isoenergetic 
diet was provided. There was an increase in fasting insulin 
resistance in the fructose group (HOMA-IR increased from 
3.6 to 4.3) but not the glucose group (3.2 to 3.4), but there 
were no significant changes in the suppression of hepatic 
glucose output or peripheral insulin sensitivity during a 
glucose clamp in either group. By contrast, when the same 
subjects were overfed, there were increases in liver fat con-
tent to approximately 10% in both the fructose and glucose 
groups, together with a trend for an increase in muscle fat of 
a similar amount. With this fructose or glucose overfeeding, 
there were no changes in HOMA-IR, and also no signifi-
cant changes in suppression of hepatic glucose production 
or peripheral insulin sensitivity during the glucose clamp, 
although there was a trend for a reduction in the latter which 
was more noticeable in the glucose-treated group. The mean 
doses of fructose or glucose provided in this study were 
around 210 g/day, which is consistent with the previous sec-
tion in which it was suggested that fructose intakes need to 
exceed 150 g/day before potentially deleterious effects are 
observed. The other conclusions from this study are that 
in overweight men with an elevated liver fat content, these 
effects are similar for fructose and glucose and are predomi-
nantly linked to overfeeding than the sugars per se [22].
This link between excessive energy intake and deleteri-
ous effects of sugars is also illustrated by the review by Te 
Morenga et al. [23], which formed part of the basis for the 
WHO Sugars and Health report [4]. This systematic review 
clearly showed that higher sugars intakes were linked to 
increased body weight or fatness if ad libitum diets were 
considered, but if sugars were exchanged for other carbo-
hydrates and energy intake was maintained constant, then 
there were no deleterious effects of sugars.
A similar conclusion arose from the SACN Carbohy-
drates and Health Report [1], with higher sugars intake 
in an ad libitum situation being associated with higher 
energy intake. This report provided a meta-analysis of the 
link between change in sugars intake and change in energy 
intake in ad libitum intake in randomised controlled trials 
which showed that the higher sugars intake (with a mean 
increase of 10%) was associated with an increased energy 
intake of approximately 1 MJ/day. Whether this repre-
sents an increased risk of developing type 2 DM, or just an 
increased risk of weight gain and eventually obesity, cannot 
be determined from these short-term RCT.
It is interesting to note that the SACN report also looked 
at cohort studies examining associations between sugars 
intake and incidence of type 2 DM. Whilst the studies iden-
tified had too much heterogeneity to allow a meta-analysis 
to be performed, it was notable that they provided no con-
sistent evidence of an association between diets differing in 
the proportion of sugars and the incidence of type 2 diabe-
tes mellitus.
A balanced overview of the current position regarding 
potential health problems arising from fructose/sucrose 
was provided by van Buul et al. [24]. They concluded that 
fructose as normally consumed in foods does not exert spe-
cific metabolic effects that would contribute to weight gain. 
They also concluded that the specific problems which have 
been identified in relation to sugars-sweetened beverages 
and risk of obesity are a result of energy overconsump-
tion rather than any effect of fructose on energy metabo-
lism or storage. However, it is clear that limiting sugars 
intake as part of a strategy to limit energy intake whilst 
at the same time increasing physical activity to increase 
energy expenditure, represent the lifestyle changes needed 
to address the current obesity problem in many countries. 
Clearly, the recent observation of potential effects of mod-
est amounts of HFCS on postprandial TG, without associ-
ated weight gain, needs to be recognised [21]. However, it 
is worth noting that the 10% HFCS that was consumed is 
double the recommended intake of 5% of energy from free 
sugars which was concluded in the SACN report.
Should we be more concerned about dietary 
glycaemic characteristics than the sugars content?
There is increasing interest in the possibility that the gly-
caemic characteristics of carbohydrates may also be of 
importance in relation to optimal health. The original con-
cept of glycaemic index was developed to help people with 
diabetes to improve their glucose control. In recent times, 
it has gained a wider application, and assessing the glycae-
mic index and glycaemic load of diets has been included 
in a number of prospective cohort studies which are sum-
marised in the SACN report [1]. This has led to several 
randomised controlled trials of potential benefits of lower 
glycaemic index diets, including a recent study of our 
own (Bawden et al. [25]) which showed that healthy non-
obese young men consuming a high glycaemic index diet 
for 7 days showed an increase in liver fat content, whereas 
7 days on a low glycaemic index diet was accompanied 
by a small decrease in liver fat. In this study, the dietary 
GI was estimated on the basis of the GI tables provided 
by Brand-Miller’s group [26]. Further work is needed to 
identify the potential impact of such differences on insulin 
resistance.
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The SACN report [1] concluded that lower glycaemic 
index diets were associated with reduced risk of cardiovas-
cular disease, but it is noticeable that most of the studies 
included in this meta-analysis also appeared in the analysis 
of associations with fibre intake, and clearly further work 
is needed to establish whether the glycaemic characteristics 
or some features of the fibre content are responsible for the 
potential health benefits. Care must also be taken in pro-
moting low glycaemic index per se, because the glycaemic 
index of fructose is very low and increasing the fructose 
content would reduce a food’s glycaemic index.
Conclusions
There is an association between diets high in sugars (pre-
dominantly sucrose) and risk of disease, and experimen-
tal studies have shown that high intakes of fructose (over 
100 g/d) can reduce insulin sensitivity, although somewhat 
lower intakes may affect serum TG. The mechanisms for 
such associations or effects have not been convincingly 
demonstrated. However, it remains to be seen whether it 
will be possible to unravel these mechanisms in the cur-
rent climate in which marked decreases in sucrose/fructose 
intakes are being promoted as key public health strategies.
Overconsumption of fructose, as a contributor to an 
excessive energy intake is linked with increased liver and 
muscle fat contents, but a similar effect is seen with glu-
cose and thus it may be more linked to carbohydrate per se, 
or possibly just to energy, overconsumption. Future work 
with overfeeding of fat is needed to explore this further.
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